ASSESSMENT OF THE DIFFERENTIATED TREATMENT OF PRIMARY PLACENTAR DYSFUNCTION IN WOMEN AGAINST THE BACKGROUND OF INFLAMMATORY DISEASES OF THE FEMALE GENITAL ORGANS

Abstract

The article presents the results of the eff ectiveness of treatment of primary placental dysfunction in women against the background of infl ammatory diseases of the female genital organs. It has been established that pregnant women with infl ammatory diseases of the female genital organs are at high risk for perinatal and postpartum complications. In pregnant women who began to receive treatment in the II trimester of pregnancy, diagnostic markers of feto-placental complex function disorders were observed much more often compared to women who received treatment for infl ammatory diseases of the female genital organs and prevention of primary placental dysfunction in the I trimester of pregnancy.Choosing the right antibacterial drug that does not have a teratogenic eff ect on the fetus and using it in the fi rst trimester of pregnancy will signifi cantly reduce the signs of pregnancy termination and signs of intrauterine infection, disorders of the intrauterine state of the fetus, premature birth and postpartum complications.